Bernie Paul - Acer Therapeutics Chief Officer
Insider
Bernie Paul is Chief Officer of Acer Therapeutics
| Age | 64 |
| Phone | 844 902 6100 |
| Web | https://www.acertx.com |
Acer Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.6527) % which means that it has lost $0.6527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7299) %, meaning that it created substantial loss on money invested by shareholders. Acer Therapeutics' management efficiency ratios could be used to measure how well Acer Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Acer Therapeutics currently holds 11.86 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Acer Therapeutics has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Acer Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Christopher Bunka | Lexaria Bioscience Corp | 62 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Jane Springer | Hoth Therapeutics | 39 | |
| Eddie Sullivan | SAB Biotherapeutics | 59 | |
| Philip Ainslie | Lexaria Bioscience Corp | N/A | |
| James Foster | Virax Biolabs Group | 40 | |
| Tiago Marques | Pasithea Therapeutics Corp | 47 | |
| Daniel Schneiderman | Pasithea Therapeutics Corp | 47 | |
| Chester III | Revelation Biosciences | 45 | |
| MD BA | Pasithea Therapeutics Corp | 76 | |
| Yassine Bendiabdallah | Pasithea Therapeutics Corp | 41 | |
| David Jin | Avenue Therapeutics | 34 | |
| Christine MBA | SAB Biotherapeutics | 69 | |
| CPA CMA | Lexaria Bioscience Corp | 63 | |
| Edward DVM | SAB Biotherapeutics | N/A | |
| MBA CMA | SAB Biotherapeutics | 69 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Jonathan MBA | Biomx Inc | 48 | |
| Merav Bassan | Biomx Inc | 59 | |
| Stefanie Johns | Hoth Therapeutics | 39 | |
Management Performance
| Return On Equity | -4.73 | |||
| Return On Asset | -0.65 |
Acer Therapeutics Leadership Team
Elected by the shareholders, the Acer Therapeutics' board of directors comprises two types of representatives: Acer Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acer. The board's role is to monitor Acer Therapeutics' management team and ensure that shareholders' interests are well served. Acer Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acer Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jefferson Davis, Chief Officer | ||
| Jason CPA, VP Controller | ||
| John Klopp, Vice President - Manufacturing | ||
| Donald JD, Chief Sec | ||
| Bernie Paul, Chief Officer | ||
| Harry Palmin, Chief Officer | ||
| Matthew Seibt, Chief Officer | ||
| Tanya Hayden, Chief Officer | ||
| MD FFPM, Chief Officer | ||
| Christopher Schelling, President CEO, Director |
Acer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acer Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.73 | |||
| Return On Asset | -0.65 | |||
| Current Valuation | 52.01 M | |||
| Shares Outstanding | 24.46 M | |||
| Shares Owned By Insiders | 13.78 % | |||
| Shares Owned By Institutions | 29.91 % | |||
| Number Of Shares Shorted | 493.55 K | |||
| Price To Earning | (7.40) X | |||
| Price To Book | 17.26 X | |||
| Price To Sales | 174.52 X |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Acer Stock
If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |